Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
Recruiting · NCT06605586 · Registry updated 2025-03-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Phase 1 / Phase 2 | 2025-03-07 | NCT06605586 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 27 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| DE-Aachen-UKAACHEN | Aachen | Germany | 2 |
| NL-Amsterdam-AMSTERDAMUMC | Amsterdam | Netherlands | 3 |
| NL-Groningen-UMCG | Groningen | Netherlands | 17 |
| NL-Nijmegen-RADBOUDUMC | Nijmegen | Netherlands | 11 |
| NL-Rotterdam-ERASMUSMC | Rotterdam | Netherlands | 14 |
| NL-Utrecht-UMCUTRECHT | Utrecht | Netherlands | 16 |